The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease

Abstract

IMAR, reflecting liver function and oxidative stress, is a more objective liver function test as it was not affected after a 3-day albumin infusion. More investigations, however, are needed to validate the use of IMAR in cases of chronic liver disease.